From sample to sequencer: IDT’s driving force behind the MRD revolution In the world of precision oncology research, minimal residual disease (MRD) has become one of the most promising areas of advancement and innovation. The ability to identify trace amounts of cancer re...

IDT has been a driving force in the #MRDresearch market since the earliest days of the field. From sample to sequencer, our end to end capabilities and expertise continue to enable innovation and help shape the future #MRD landscape. Read more from Ajay Gannerkote: www.linkedin.com/pulse/from-s...

We are excited to attend the Precision Medicine World Conference (#PMWC26) this year! Join us at booth #B722 to explore how IDT supports over 80% of the #MRDresearch market with high quality manufacturing, advanced technologies, and trusted partnerships.

Learn more: pmwcintl.com